Investing.com - Teva ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Teva ADR announced earnings per share of $0.59 on revenue of $3.6B. Analysts polled by Investing.com anticipated EPS of $0.62 on revenue of $3.85B.
Teva ADR shares are down 39.61% from the beginning of the year and are trading at $8.35 , down-from-52-week-high.
Teva ADR shares lost 4.68% in pre-market trade the report.
Teva ADR follows other major Healthcare sector earnings this month
Teva ADR's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar